Olivier Elemento, PhD


Olivier is the Scientific Co-Founder of OneThree Biotech.

He is a professor at Weill Cornell Medicine, where he directs the Caryl and Israel Englander Institute for Precision Medicine, a translational institute that combines genomics and AI to personalize medicine and uncover mechanisms that cause disease.

He is also the Co-Director of the Institute for Computational Biomedicine and Associate Program Director of the Clinical and Translational Science Center. His group develops novel experimental and computational approaches for enhancing personalized medicine together with AI methods to bring drugs to patients faster.

He has published over 230 scientific papers and also co-founded Volastra Therapeutics to develop anti-metastasis therapies.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound